Abstract:Purpose of review: Atherosclerosis (AS) is a chronic inflammatory disease that contributes to the development of coronary artery disease, which has become a leading health burden worldwide. Though several strategies such as pharmacological treatment, exercise intervention, and surgery have been used in clinical practice, there is still no effective strategy to cure AS. Exosomes are extensively studied both as diagnostic markers as well as for therapeutic purposes due to their role in pathological processes related to AS. To elucidate the role of exosomes in AS and thus provide a new insight into AS therapy, we review recent advances concerning exosome targets and their function in mediating intercellular communication in AS, and expect to provide a reference for novel effective strategies to cure AS. Recent findings: Exosomes exert important roles in the diagnosis, development, and potential therapy of AS. For AS development, (1) activation of CD-137 in endothelial cells represses exosomal-TET2 production, causing a phenotypic switch of vascular smooth muscle cells (VSMC) and promoting plaque formation; (2) exosomal-MALTA1 derived from endothelial cells causes neutrophil extracellular traps (NETs) and M2 macrophage polarization, which aggravates AS; and (3) exosomal-miR-21-3p derived from macrophages inhibits PTEN expression and further promotes VSMC migration/proliferation, leading to AS development. For AS diagnosis, plasma exosomal-miR30e and miR-92a are considered to be potential diagnostic markers. For AS therapy, adipose mesenchymal stem cell-derived exosomes protect endothelial cells from AS aggravation, via inhibiting miR-342-5p. Exosome-mediated cross-talk between different cells within the vasculature exerts crucial roles in regulating endothelial function, proliferation and differentiation of vascular smooth muscle cells, and platelet activation as well as macrophage activation, collectively leading to the development and progression of AS. Exosomes can potentially be used as diagnostic biomarkers and constitute as a new therapeutic strategy for AS.

Microparticles (Exosomes) and Atherosclerosis

Exosomes in atherosclerosis: performers, bystanders, biomarkers, and therapeutic targets

Exosomes in Atherosclerosis: Role in the Pathogenesis and Targets for Therapy

Exosomes: Multifaceted Messengers in Atherosclerosis

Exosomes: emerging roles in communication between blood cells and vascular tissues during atherosclerosis

Exosomes and Atherogenesis

Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis

Exosomes in Atherosclerosis, a Double-Edged Sword: Their Role in Disease Pathogenesis and Their Potential as Novel Therapeutics

Exosomes in atherosclerosis: Convergence on macrophages

Exosomes and Their Derivatives As Biomarkers and Therapeutic Delivery Agents for Cardiovascular Diseases: Situations and Challenges.

Platelet-Derived Exosomes in Atherosclerosis

Mechanisms of Action of MiRNAs and LncRNAs in Extracellular Vesicle in Atherosclerosis

Extracellular Vesicles as Mediators in Atherosclerotic Cardiovascular Disease

The Exosome-Derived Biomarker in Atherosclerosis and Its Clinical Application

Exosomes in Coronary Artery Disease.

Exosomes: mediators regulating the phenotypic transition of vascular smooth muscle cells in atherosclerosis

Roles of Extracellular Vesicles Derived from Immune Cells in Atherosclerosis

Therapeutic Exosomes in Prognosis and Developments of Coronary Artery Disease

Emerging Role of Exosome-Mediated Intercellular Communication in Vascular Remodeling

Extracellular vesicles as biomarkers and modulators of atherosclerosis pathogenesis

Advances in the study of exosomes in cardiovascular diseases